Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sigalit Kay
Observed names:
S KAY,
S Kay,
S. Kay
Observed institutions:
St Thomas' Hospital,
Tel Aviv University,
Mid Cheshire Hospitals NHS Foundation Trust,
Tel Aviv Sourasky Medical Center,
Kuwait University,
Novartis (Canada)
show all 6
OpenAlex ID:
A5111690689
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
2018
·
Guy Ledergor
, Assaf Weiner
, et al.
·
Nature Medicine
·
262
Ultrastructural studies of a malignant fibrous mesothelioma of the pleura.
1971
·
S Kay
, S G Silverberg
·
PubMed
·
53
Pathogenesis and treatment of plunging ranulas.
1977
·
W E Roediger
, S Kay
·
PubMed
·
28
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
RECOVERY Collaborative Group
, Peter Sandercock
, et al.
·
Nature Communications
·
11
PDF
Sulphasalazine rectal enemas: topical method of inducing remission of active ulcerative colitis affecting rectum and descending colon.
1977
·
H Serebro
, S Kay
, et al.
·
BMJ
·
9
PDF
B cells in thymomas.
1990
·
M J Kornstein
, S Kay
·
PubMed
·
6
The Prognosis of Gastric Carcinoma as Related to Its Morphologic Characteristics.
1964
·
C MARTIN
, S KAY
·
PubMed
·
6
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Biological behavior and cell properties of new AKR lymphoma malignancy variants
1998
·
O. Klein
, A. Staroselsky
, et al.
·
Tissue and Cell
·
5
Apoptosis, cell proliferation and in vivo biological behaviour of primary and metastatic tumour cells of an AKR lymphoma variant
1997
·
N. Donin
, D. Katzenelson
, et al.
·
APOPTOSIS
·
5
Release from apoptosis correlates with tumor progression in the AKR lymphoma
2000
·
Sigalit Kay
, Natalie Donin
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
·
3
PDF
Apoptosis and Cell Proliferation Capacity in AKR Lymphoma Malignancy Variants
2000
·
Natalie Donin
, Sigalit Kay
, et al.
·
Cancer Investigation
·
2
Cushing's syndrome with nodular adrenal hyperplasia.
1969
·
H S Tucker
, H L Estep
, et al.
·
PubMed
·
2
PCN23 Overall Survival Estimates Adjusting for Treatment Crossover in Patients Previously Untreated with an ALK Inhibitor with ALK+ NSCLC Using DATA from the Alta-1L Clinical Trial
2020
·
H. Cranmer
, Y. Liu
, et al.
·
Value in Health
·
1
PDF
Sensitivity to Macrophages Decreases with Tumor Progression in the AKR Lymphoma
2002
·
T. Kaptzan
, E. Skutelsky
, et al.
·
Advances in experimental medicine and biology
·
1
Apoptotic cell death and related gene expression in metastatic tumors of AKR lymphomas of varying malignancy
1999
·
S. Kay
, M. Michowitz
, et al.
·
APOPTOSIS
·
1
Sulphasalazine retention enemas in ulcerative colitis.
1981
·
H A Serebro
, S Kay
·
BMJ
·
1
PDF
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
POSB16 Overall Survival Indirect Treatment Comparison Results Adjusted for Treatment Crossover: Brigatinib Relative to Alectinib in Patients with ALK+ NSCLC Previously Untreated with an ALK Inhibitor Using the Final Results from Alta-1L and Alex
2022
·
H Cranmer
, HM Lin
, et al.
·
Value in Health
PCN143 – Sandostatin Lar Patient Journey
2014
·
Cameron L. Macdonald
, S. Kay
, et al.
Sandostatin Lar Patient Journey
2014
·
C. MacDonald
, S. Kay
, et al.
·
Value in Health
Show more works
View as search
Works count:
22
Citation count:
413
H-index:
6
I10-index:
5
Year
Topic
Type